Hillhouse Capital Management as of Dec. 31, 2016
Portfolio Holdings for Hillhouse Capital Management
Hillhouse Capital Management holds 34 positions in its portfolio as reported in the December 2016 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
Jd (JD) | 55.0 | $2.5B | 97M | 25.44 | |
Mondelez Int (MDLZ) | 8.8 | $395M | 8.9M | 44.33 | |
Enstar Group (ESGR) | 7.7 | $346M | 1.8M | 197.70 | |
priceline.com Incorporated | 6.1 | $275M | 188k | 1466.06 | |
Baidu (BIDU) | 4.5 | $203M | 1.2M | 164.41 | |
58 Com Inc spon adr rep a | 3.5 | $155M | 5.6M | 28.00 | |
Melco Crown Entertainment (MLCO) | 2.6 | $116M | 7.3M | 15.90 | |
Sina Corporation | 1.9 | $86M | 1.4M | 60.79 | |
Ctrip.com International | 1.8 | $79M | 2.0M | 40.00 | |
Sohu | 1.2 | $56M | 1.7M | 33.89 | |
TAL Education (TAL) | 0.9 | $42M | 599k | 70.15 | |
Beigene (BGNE) | 0.9 | $41M | 1.4M | 30.36 | |
Momo | 0.8 | $38M | 2.1M | 18.38 | |
WebMD Health | 0.6 | $28M | 555k | 49.57 | |
Fibrogen (FGEN) | 0.5 | $21M | 1.0M | 21.40 | |
Intra Cellular Therapies (ITCI) | 0.3 | $15M | 1.0M | 15.09 | |
Blueprint Medicines (BPMC) | 0.3 | $14M | 483k | 28.05 | |
Acceleron Pharma | 0.3 | $13M | 500k | 25.52 | |
Zto Express Cayman (ZTO) | 0.3 | $12M | 1.0M | 12.07 | |
Line Corp- | 0.3 | $12M | 337k | 34.01 | |
Cameco Corporation (CCJ) | 0.2 | $11M | 1.0M | 10.47 | |
Proteostasis Therapeutics In | 0.2 | $11M | 866k | 12.26 | |
Theravance Biopharma (TBPH) | 0.2 | $9.7M | 304k | 31.88 | |
Ac Immune Sa (ACIU) | 0.2 | $7.1M | 550k | 12.98 | |
Tigenix | 0.2 | $7.1M | 484k | 14.58 | |
Clearside Biomedical (CLSD) | 0.1 | $5.4M | 600k | 8.94 | |
Fang Hldgs | 0.1 | $4.9M | 1.5M | 3.28 | |
Nabriva Therapeutics | 0.1 | $4.2M | 700k | 5.95 | |
Prothena (PRTA) | 0.1 | $3.7M | 75k | 49.19 | |
Paypal Holdings (PYPL) | 0.1 | $3.0M | 75k | 39.48 | |
Xunlei Ltd- (XNET) | 0.0 | $1.6M | 403k | 3.86 | |
Alibaba Group Holding (BABA) | 0.0 | $813k | 9.3k | 87.78 | |
Lendingclub | 0.0 | $525k | 100k | 5.25 | |
Seres Therapeutics (MCRB) | 0.0 | $209k | 21k | 9.91 |